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D99564 UnchangedFunctionandDensitYOf
SR-Ca2+-RalaaseChannelsinthe FailingHuman
Myocardiumcomparedto Nonfsiling
R.H.G. Schwinger, M. Pietsch, K. Brixius, J. MOller-Ehmsen.kmerekfedizin
///,UniversittitKtW,KOln,Germany
In the failing human myocardium due to dilated cardiomyopathy intracel-
lular Caz+-handling is alterad and has been suggested to result from an
impaired SR-Ca2+-uptske ancf/or-releaae. The present study aimed to in-
vestigate the density the Ca2+-release channels of sarcoplasmic reticu-
lum (ryanodine binding sites, RYA, 3H-ryanodine) and of fl-adrenoceptore
(fJAR, 125J-cyanopindolol,CYP) using radioligand binding experiments. In
Saponina+kinned skinned fiber preparations (5o Kg saponina/ml, 30 rein,
4W) from the very same human failing (NYHA IV, heati transplants, dilated
cardiomyopathy, n = 13) and nonfailing myocardium (NF, donor hearts, n =
7) the mffeine (10 mM)-inducad Ca2+-release was measured at pCa 5 to 7.
The density (B~~) of RYA was unchanged in NYHA IV (RYA 2.0 + 0.2
pmol/mg protein) compared to NF (RYA: 2.0 + 0.2 pmollmg protein); in
contrast, PAR were significantly reduced in NYHA IV compared to NF. The
affinity of the radioligands was identical in NYHA IV and NF (RYA: NYHA IV
1.9 nM; NF 1.6 nM). The maximal coffeine-inducad tension as a measure
of SR-Ca2+-releaeefunction was identical in NF and DCM (pCa 7, NF: 15.9
k 2.2% of maximal tension, DCM: 19.9 + 3.8% of maximal tension) but
occurred in DCM at lower free Ca2+-concentrations.
In conclusion, the altered intracellular Ca2+-homaostasis reportad in di-
lated cardiomyopathy may be not due to changes in the density of the
saroopiasmic reticulum Ca2+-release channel (RYA). The enhanced Ca2+-
sensitivity could be indicative of an altered regulation of the Ca2+-release
channel in diseased human myocardium.
D99565 PeptidesCorrespondingto Both01 andMuacarinic-2ReceDtorsInducedHvoeRroDhic
Cardiomyopathyi; Rsbbits ‘. .
S. Matsui, S. Katauda, M. Fu 1, M. Hayase, N. Yamaguchi, K. Teraoka,
T. Kurihara, T. Asaji, N. Takekoshi, E. Murakami. KanazawaMedical
UniversityJapan,1GoteborgUniversitySweden
The high prevalence of dilated cardiomyopathy (DCM) patients with anti-
~1 and/or anti-muscarinic-2 (M2) receptor(s) autosntibodies in theirsers has
been obsewed. However,the pathophysiobgicsd roleof these autoantibafies
in the development of cardiomyopathy has remained unknown. We have
repotted that each of the synthetic peptides corresponding to the sequences
of the 2nd extracellular loops (2ECL) of the human 51 and M2 receptors
induces DCM-like cardiomyopathy in immunized rabbits (18th Congress of
ESC, 1996). Inthiastudy, reattempted to inducecardiomyopathy by monthly
immunizing rabbits (n= 6) for one year with synthetic peptides corresponding
to the sequences of 2ECLS of both human pl and M2 receptors. All rabbits
immunized with both peptides had the high titre of both anti-pi and anti-M2
autosntibodies in their sera, whereas none of the sera from control rabbits
injectedwith saline (n =6) was positive. Theweightoftha heads of immunized
rabbits increased significantly. The hearts of immunized rabbits showed
marked concentric LV hypartrophy with mild inflammatory cell infiltration.
In these rabbits, mild or moderate interstitial fibrosis was also obsemd.
In alsctron micrographs, immunized rabbits showad focal myofibrillar Iysis,
Ioas of myofilament, marked increase in the number of mitochondria and
deposition of dense granules both in the sarcoplasma and myofibrils. On
the other hand, one of the control rabbits showed scant mononuclear cell
infiltration. But, in this control rabbit, no significant alteration was found by
electron microscopy. Our results demonstrated that coexistence of troth anti-
p’1and anti-M2 receptor autoantibodies in the sera have psthophysiological
importance aa shown by their ability to induce hypertrophic cardiomyopathy
in rsbbite.
D99566 Regulationof ExtracellulsrMatrixProteins(ECM)ins Modelof LeltVentricularHypertrophy(LVH).
Contributionofthe Renin-Angiotensin-System
(RAS)
D.G. Grimm, H. Schunkert, G. Bruckschlegel, G. Riegger, E.P.Kromer.
UniveIWfyofRegensburg,Germany
Pressure overload LVH is characterized by oardiomyocyte growth as well as,
remodeling of ECM components. The aim of this study was to quantitatively
examine the effects of ramipril (RAM) on ECM proteins. LVH was induced in
weanling rats by banding of the ascending aorta. Animals were treated with
vehicle (VEH: n = 10), hydralszine (HYD: 20 mglkg BW/d; n = 10), or RAM
(10 mg/kg BW/d; n = 10) during weeks 6-12 after banding. As compared
to ahams (n = 10), relative LV-weight was elevated in the VEH-and HYD-
treated groups (1.6-l .6-fold). RAM blunted LVH significantly (p c 0.001).
Using QIA, VEH-and HYD-treated rats revealed a significant increase of
cardiac myocyte cell volume (p < 0.05), as well as induction of parivasccdar
(2.5-fold, p < 0.01) and interstitial fibrosis (3.5-fold, p c 0.01). In contrast,
RAM-treatad rats displayed attenuation of LVHand perivascularfibrosis (1,7-
and 1.I-fold vs sham, p c 0.05 and p = ns), that was significantly lower than
in VEH- and HYD-rats (p <0.01, each). Blood pressure reduction by HYD
or RAM treatment was similar (21 + 5 and 25 + 4 mmHg). VEH and HYD
rats were characterized by mRNA levels of collagen I (1.97- and 1.64-fold,
p < 0.001), collagen Ill (both 2.16-fold, p < O.COl)and Iaminin B (1.57- and
1.6-fold, p < 0.005). Furthermore, the corresponding immunohistochemical
signals were markedly increased. In addition, gene expression of collagen I
and Ill as well as Iaminin B was closely correlated to LV/BW (all r = 0.55, p
< 0.0001). Aa compared to VEH and HYD groups, RAM significantly bluntad
the increase of collagen I and Ill as well as Iaminin B mRNAs and proteina
were significantly lower in RAM treated rats (all p <0.05 vs VEH and HYD).
In conclusion, blockade of the RAS may limit the effects of left ventricular
pressure overload on myocyte hypetlrophy, as well as remodeling of ECM
components, and fibrosis.
p{ Decrea~dRetinoid~acaPtorBindingin
Preasure-OvarloadedMyocardium
P.S.Pollack, L.M. Pasquarello, K.J. Soprano. TempletkriveraiiyScko/of
Medicine,Philadelphia,PA,USA
Retinoid pathways suppress the development of the hypertrophic phenotype
in vitro and the effects are mediated via retinoic acid receptors (RARa) and
retinoid X receptors (RXRS).We studied RAR and RXR binding in the feline
LV following aortic banding. LV function and the development of LVH were
monitored by achocardiography. Nuclear extracts were prepared and elec-
trophoretic mobility shift assays (EMSAS)were performed to aasess binding
to RAFURXRand RXWRXR consensus sequences. Immunohistochemical
staining was performed with a polyclonal antibody to RXR alpha.
Resu/ts:Septal wall thickness was increased 1 month after aortic banding
(0.45 sc0.07 vs. 0.26+ 0.03 cm; p < 0.001). LV diastolic dimension (1.2A
0.2 vs. 1.2 + 0.1 cm) and% fractional shortening (49 + 6 vs. 54 + 6) were
not significantly different in banded and sham-operated heark.
Nuclear extracts from aonic and sham-banded animals produced a shift
to both RAWRXR and RXWRXR consensus sequences by EMSA. Binding
activity to both sequences was decreased in the extracts from the hypertro-
phiad hearts. Binding was competitively inhibitad by excess unlabeled probe.
Immunoreactive RXRalpha was present in myocyte nuclei from both banded
and sham-operated IIearrs.
Conclusions:Retinoid receptor binding is decreaaed in compensated
LVH seconda~ to pressure-overload and these changes maybe mediated,
at least in part, via the RXR alpha isoform. These findings suggest that there
are alterations in transcriptional activation by retinoid receptors in pressure-
overload hypertrophy.
-[ Efle~oflncreasedAfier,oadon~,oba,and
RegionalMechanicalHeterogeneityof Left
Ventricle
M. Sakaki, M. Komeda, S.D. Nikolic. StanfordUniveraityandF’a/oAlto
MedicalFoundation,PaloAlto,CA,uSA
Nonuniform myocardial motion of the normal LVwas studied in 8 open-chest
swine. Sixteen multidirectional digital ultrasonic crystals were implanted to
measure circumferential (circ) and longitudinal (long)segment lengths and
chamber diametere with high frequency of sampling (> 100 Hz). Crystal
arrays were determined by 3 circlevels (basal, equatorial and apical), 5 long
meridians (two septal, anterior, lateral and posterior free wall) and apex.
LV pressure was used to determine the time of end-diastole (time of 8%
dp/drt.4Ax)and end-systole (time of dP/dtMIN).We determined normalized
time delay (% of RR interval) of the start of shortening with respect to
end-diastole, and the start of lengthening with respect to end-systole for 17
regional segment lengths and 14 global chamber diameters. We compared
LV regions (defined as pooled segment lengths or diameters) in control (C)
beat vs. beat at the peak of the partial aorfic mnstriction (AoC). Resu/ta:
(mean & SEM; *p <0.05 Tukey test between the regions) SegmentIengtha:
“apical vs. basal”: Apical region starts shorteningearlier in both C and AoO
(C; 11+ 1.5vs. 16 & 1.5*, AoC; 13+2.2 vs. 22 + 2.3*), and Iengtheninglater
in C (C; 14+ 1.6va. 6.8+ 1.6*, AoC; 14+ 1.9vs. 10+ 1.9 ns). “circvs. long”:
Segment Iengtha in circ dirac!ion start shorteningearlier (C; 9.8 + 1.2 vs. 15
+ 1.38,AcC; 13+ 1.7vs. 21 + 1.8;), and /engtheningearlier(C;8.8+ 1.2vs.
15+ 1.3”,AoC; 7.7+ 1.3vs. 16 + 1.5*). Diamefer.%’’apicalva. basal”: Apical
diameters stat shortening simultaneously and lengtheninglater (C; 14& 2.1
vs. 4.8 & 1.9*, AoC; 11+ 1.9vs. 3.2+ 1.8*). “tranavaraevs. long”: Transverse
diameters start shorteningearlier (C; 11 + 1.8 vs. 17+ 1.3”, AoC; 15 + 2.5
vs. 21 + 1.7*), and lengtheningearlier (C; 6.7 + 2.1 vs. 2 + 1.5*, AoC;
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6.7 + 1.9 vs. 13 + 1.4”). Conclusions: 1. LV exhibits dominant “peristaltic”
segment lengths motion pattern of mechanical heterogeneity: apex-to-base
shortening and base-to-apex lengthening sequence; 2. Increased afterload
changes thia pattern to more homogeneouslengthening.
m99569 MagneticResonanceImagingAseeaamantofRegionalMyocardialFiberandCrosa-fiberStrain
D.C. Bloomgarden, V.A. Ferrari, A.A. Young, D.L. Kraitchman, Z.A. Fayad,
L. Axel. Urriv of PA, Phi/a., PA, USA, Urri~ of Auckland, Auck/and, AfZ,USA
Myocardial fiber orientations areorganized consistency.Noninvasive studies
(assuming homogeneous strain) and invasive canine studies under non-
physiological conditions have demonstrated greater subendocerdial cross-
fiber(XF) shortening than fiber shortening. We reexamined this phenomenon
using high resolution MRtegging and nonhomogeneous analysis under phys-
iological hemodynamic conditions. We imaged four normal dogs using MRI
with tissue tagging in shori and long axis planes. Three-dimensional finite el-
ement modeling was used to reconstruct the nonhomogeneous deformation
field of the entire LV.Strain was extracted from the model and referenced to
the fiber and XF directions, using a quantitative fiber field database, at all tag
intersections (- 1350/dog). Data were divided into 36 regions (3 longitudinal
levels, 4 circumferential sectors, and 3 transmural depths). The table shows
repreaentative average regional shortening straina at the midventricle. Fiber
strain varied by only 6’Yoover all regions, compared to 15% for XF strain. XF
strain was greater in the subendocardiurntha in the subepicardium in all
regions, and XF strain was greater than fiber strain throughout the suben-
docardium. High resolution MR tagging with nonhomogeneous 3D analyais
demonstrates striking differences in fiberafid cross-fiber strains in the normal
LV.
Anterior Lateral POstariOr Septal
Endo
-0.15 %9 %4 ::: %3%3%0
Epi
Fiber Strain –0.14
Cross-Fiber Strain –o.18# –0.07 –0.1s” –0.05 –0.1s -0.13 -0.15 –0.10
*p <0,01 endo va epi withinregion;#p <0.03 endovs epi withinregion
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]996-51 ] EfiedsofAn9iotenain~onveflin9~n~Yme
Inhibitor on NitrateToleranceDuringTranedermal
Applicationof Nitroglycerin
H. Watanabe, M. Kakihana’, S. Ohtsuka, Y. Sugishite. LhWersityof
Tsukuh, Tsukubs,Japan, 1Ibaraki Prefectural Universi~ of’Health
Sciences, Ibsraki, Japan
Continuous application of nitroglycerin (NTG) has been shown to result in the
development of nitrate tolerance. The attenuation of intracellular production
of cGMP has been known aa an important mechanism of nitrate tolerance.
Thia study waa designed to investigate the effects of angiotenain mnverting
enzyme (ACE) inhibitors, captopril with a SH group and enalapril without a
SH group, on nitrate tolerance. in 15 patients with congestive heart failure,
platelet cGMPlevels (pmol/l OgPLT)andforearrmblood flow (FBF,mVmifVIOo
ml arm) by plethysmography were measured before and 5 minutes after
sublingual administration of 0.6 mg NTG at the following four phases: (1)
Control phase, (2) NTG phase (1 week after application of transdermal NTG
tape 10 m@24 hr), (S) CPT phase (1 week after both ceptopril 75 mg/day
and NTG tapa), and (4) ENL phase (1 week after both enalapril 10 m@day
and NTG tape). Before sublingual NTG, platelet cGMP levels (NTG: 0.44 +
0.12, CPT: 0.52+ 0.11, ENL: 0.41 + 0.18, p c 0.05 vs control, ANOVA) and
FBF (NTG: 3.3 + 0.5, CPT: 3.5 A 0.4, ENL: 3.5 + 0.5, p <0.05 va control,
ANOVA) were significantly higher at three phases with NTG tape than the
control phase (cGMP: 0.33 + 0.17, FBF: 2.7 + 0.5). The parentage of the
increase of platelet cGMP (% cGMP) and FBF (% FBF) after sublingual
NTG were significantly Iesa at the NTG phase than the control phase (ok
cGMP: 8 + 2 VS 36 + 5, p < 0.01; 7. FBF: 15 + 4 VS 32 + 8, p <0.01,
control phase va NTG phase). In contract, concomitant application with ACE
inhibitors maintained % cGMP (CPT:37+7, ENL: 30+5) and% FBF (CPT:
30& 8, ENL: 31 +7) campared with the control phase. Conclusions: These
results indicate that concomitant therapy with ACE inhibitore may be helpful
to prevent the attenuation of the production of cGMP and vasodilation during
continuous transdermal application of NTG.
IEEz.1ResponaeofB’ac’Hea~Fai’urepat’ent’toCarvediloi
C,Yancy, M.B. Fowler, W.S. Colucci, E.M. Gilbert, MA. Lukae, S.T.Young,
for the US Carvedilol Heart Failure Study Group. University of Texas
Southwestern, Da//as, TX, USA
To determine whether or not race might beaasociated with an altered efficacy
or safety profile when receiving therapy with p-blockade in heart failure, we
compared outcomea among black patiants randomized (double-blind) to
placebo or cervedilol (CRV), a multiple-action drug with & and a-blockade
and antioxidant properties, in the US Carvedilol Heart Failure Trials Program.
This study of 1,094 NYHA Class II-IV patients (LVEFs 35%), included 217
(20%) blacks (B), and 608 (74%) Caucasians (C). The mean exposure for C
(166 days) and B (167 days) was eimilar, during which existing therapy with
digoxin, diuretics andlor ACE inhibition was maintained.
Resu/ts: (Relative risk; 95% confidence intewals; interaction P value)
Race Mortality CardiovascularHospitali- WorseningHeart Failure
p = 0.s05 zation p = 0.342 Hospitalizationp = 0,714
c 0,34 (0.17, 0.67) 0.65 (0.46, 0.91) 0.52 (0.31, 0.S7)
B 0.53 (0,16, 1.52) 0.61 (0.29, 1,24) 0.47 (0.14, 1.61)
Adverse events associated with &blockade (fatigue [24% C, 18% B],
cardiac failure [16Y0C, 17Y0B] and bradycardia [7% C, 5% B]) were similar
in incidence although vasodilation (dizzineas [26% C, 33% B], hypotension
[9% C, 16% B]) waa less common in C.
Cone/usion:Blackpatients treated with CRV had similar reductions in their
risk of death and hospitalization, and exhibited a high degree of tolerability
of therapy.
1996-53] ShouidLowB100dPree5UreprGciIJdeinitiationOf
BetaBlockerTherapyinCongestiveHeartFailure?
J. Kalman, D.K. Levy, M.M. Mannino, R.S. Freudenberger, C. Buchholz,
O.N. Ocampo, M.L. Kukin. The Cardiovascular /nstitute, Mount Sirrai Scfroo/
of Medicine, New York,NY USA
There ia now accumulating evidence of the benefit of fl-blocker (P-B) therapy
in refracto~ heart failure. However, many physicians are un$feretandably
ralucfant to initiate B-B therapy when the systolic blood pressure (SBP)
is below IWJ mmHg. We compared the safaty and efficacy of metoprolol
according to the initial BP in 57 consecutive pts enrolled in B-B protocols.
All pts were on chronic background therapy (digoxin, diuretics, and ACEI)
with a pulmonary cspilla~ wedge pressure (PCW, mmHg) 214. There were
16 pts with SBP s 100 (Low BP) and 41 with SBP >100. Pts were NYHA
II - IV, with 70Y0 in NYHA Ill. Aside from BP derived variables, baseline
parameters were similar in both groups. Baseline (B) and 3 month (LT)
variables of SBP, heart rate (HR, bpm), PCW, aystemic vascular resistance
(SVR, d-s-c), stroke work index (SWI, gm-rnlm2), and ejection fraction (EF)
are shown. (*p <0.05 vs. B w/in grp, #p <0.05 btw grp B to LT)
SBP HR Pcw SJR Swl EF
Low BP: S 94 S9 26 1211 16.5 In
Low BP: LT 101” 67* 18” 1055 31.5* ‘-14*
BP> 100: B 118 Ss 2s 1330 23.1 13
BP > 100: LT 112*# 71” 21” 996* 32,4* “-18*
Nine pts did not complete the study (5: SBP > 100,4: Low BP; p = NS).
The average $ in NYHAwas 1 class while submaximal and maximal exercise
Tin both grps (btw grps; p = NS).
In summary, both grps improved with O-Btherapy with no btw grp differ-
ence in response other than the surprising T in SBP in the low BP grp. Thus,
asymptomatic hypotension does not preclude initiation or response to P-B
therapy.
-1 Threa-YearFoiiOv+UpOf~h.MetoPrololinDiiated
CardiomyopathyTrial
B. Andereson, F.Waagstain. Div. of Cardiology, Sah/grenska University
Hospital, G6teborg, Sweden
The international multicenter Metoprolol in Dilated Cardiomyopathy (MDC)
trial was the first major placabo-controlled trial using beta-blcckera in con-
gestive hea~ failure. The study recruited 383 patients with idiopathic dilated
cardiomyopathy. During the 18 months of the study there was a 34% re-
duction in the primary endpoint, death or need for haarf transplantation (p=
0.058). The aim of the present investigation was to evaluate long-term follow-
up in patients participating in the MDC-trial. Death or heart transplantation
was considered as endpoint.
